Baseline PET/CT imaging parameters for prediction of treatment outcome in Hodgkin and diffuse large B cell lymphoma: a systematic review
Purpose To systematically review the literature evaluating clinical utility of imaging metrics
derived from baseline fluorine-18 fluorodeoxyglucose positron emission …
derived from baseline fluorine-18 fluorodeoxyglucose positron emission …
Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group
Purpose Recent advances in imaging, use of prognostic indices, and molecular profiling
techniques have the potential to improve disease characterization and outcomes in …
techniques have the potential to improve disease characterization and outcomes in …
Metabolic tumor volume metrics in lymphoma
Although visual assessment using the Deauville criteria is strongly recommended by
guidelines for treatment response monitoring in all FDG-avid lymphoma histologies, the high …
guidelines for treatment response monitoring in all FDG-avid lymphoma histologies, the high …
Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL
NG Mikhaeel, D Smith, JT Dunn, M Phillips… - European journal of …, 2016 - Springer
Background The study objectives were to assess the prognostic value of quantitative PET
and to test whether combining baseline metabolic tumour burden with early PET response …
and to test whether combining baseline metabolic tumour burden with early PET response …
Molecular profile and FDG-PET/CT total metabolic tumor volume improve risk classification at diagnosis for patients with diffuse large B-cell lymphoma
Purpose: The prognostic impact of total metabolic tumor volume (TMTV) measured on
pretreatment 18F-FDG PET/CT and its added value to molecular characteristics was …
pretreatment 18F-FDG PET/CT and its added value to molecular characteristics was …
Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma
H Ilyas, NG Mikhaeel, JT Dunn, F Rahman… - European journal of …, 2018 - Springer
Purpose Metabolic tumour volume (MTV) is a promising prognostic indicator in diffuse large
B cell lymphoma (DLBCL). Optimal thresholds to divide patients into 'low'versus 'high'MTV …
B cell lymphoma (DLBCL). Optimal thresholds to divide patients into 'low'versus 'high'MTV …
Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma
L Ceriani, M Martelli, PL Zinzani… - Blood, The Journal …, 2015 - ashpublications.org
Abstract The International Extranodal Lymphoma Study Group (IELSG) 26 study was
designed to evaluate the role of 18F-fluorodeoxyglucose (18FDG) positron emission …
designed to evaluate the role of 18F-fluorodeoxyglucose (18FDG) positron emission …
Prognostic value of baseline metabolic tumor volume and total lesion glycolysis in patients with lymphoma: a meta-analysis
B Guo, X Tan, Q Ke, H Cen - PloS one, 2019 - journals.plos.org
Whether baseline metabolic tumor volume (TMTV) and total lesion glycolysis (TLG)
measured by FDG-PET/CT affected prognosis of patients with lymphoma was controversial …
measured by FDG-PET/CT affected prognosis of patients with lymphoma was controversial …
Smart start: rituximab, lenalidomide, and ibrutinib in patients with newly diagnosed large B-cell lymphoma
J Westin, RE Davis, L Feng, F Hagemeister… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE Chemoimmunotherapy for patients with newly diagnosed diffuse large B-cell
lymphoma (DLBCL) is largely unchanged for decades. Both preclinical models and clinical …
lymphoma (DLBCL) is largely unchanged for decades. Both preclinical models and clinical …
[HTML][HTML] Role of fluorodeoxyglucose positron emission tomography/computed tomography in predicting the adverse effects of chimeric antigen receptor T cell therapy …
J Wang, Y Hu, S Yang, G Wei, X Zhao, W Wu… - Biology of Blood and …, 2019 - Elsevier
ABSTRACT CD19-targeting chimeric antigen receptor (CAR)-T cell therapy has shown great
efficacy in patients with relapsed/refractory non-Hodgkin lymphoma (NHL) but has been …
efficacy in patients with relapsed/refractory non-Hodgkin lymphoma (NHL) but has been …